Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

We have observed 5 EP applications Eva Susanne Ehlich has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14169050

Transdermal therapeutic system for administering the active substance buprenorphine

IPC classification:
A61K 9/70, A61K 31/485
Applicant:
LTS LOHMANN Therapie-Systeme AG
Agent:
Eva Susanne Ehlich, Maiwald Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12813099

PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY (EPSILON- CAPROLACTONE) AND POLYETHYLENE OXIDE

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/48
Applicant:
Purdue Pharma L.P.
Agent:
Eva Susanne Ehlich, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP14171110

Transdermal delivery system

IPC classification:
A61K 9/70, A61K 31/485, A61P 25/04
Applicant:
LTS LOHMANN Therapie-Systeme AG
Agent:
Eva Susanne Ehlich, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP11819221

IMPROVED ENTERIC ACTIVE SUBSTANCE DELIVERY

IPC classification:
A61K 9/48, A61K 9/52, A61K 38/28, A61K 39/145
Agent:
Eva Susanne Ehlich, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP12889630

METHOD FOR MANUFACTURING ELECTRICAL DOUBLE LAYER CAPACITOR ELECTRODES

IPC classification:
H01G 11/24, H01G 11/38, H01G 11/84
Agent:
Eva Susanne Ehlich, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature